Binay Shah

@drbinayshah.bsky.social

Hematologist/Oncologist; Co-Founder, President & CEO, Binaytara | Advocate for Equitable Healthcare Access | Innovator in Oncology Education and Global Health https://binaytara.org

Met with @binaytara.bsky.social’s leadership team in Nepal—great to see the strong progress being made. We’re expanding our work in cervical cancer screening and gearing up to begin construction of a cancer hospital soon. Exciting times ahead as we continue working to improve access to cancer care.

Bild

Targeted therapies and biomarkers are here. Dr. Shivaani Kummar explores why adoption lags behind science and how better trial design, dose optimization, AI-driven biomarkers, and cancer interception could reshape the next era of oncology: buff.ly/qeMaOkV

Bild

We're proud to see our co-founder, @drbinayshah.bsky.social, contributing to important public health conversations. He was recently featured in WFLA discussing a growing trend in oncology: over 90% of doctors surveyed have had patients asking about #Ivermectin for cancer treatment: buff.ly/KmBSCz9

DeSantis likely to sign bill allowing Ivermectin over the counter

In a social media post, Gov. Ron DeSantis said he’s pushing the legislature to pass a bill involving Ivermectin and he plans to sign it.

wfla.com

🏆 Honored to be named Runner-Up at the 2025 Global Design & Architecture Awards! The Binaytara Cancer Hospital by Fong & Chan Architects will bring world-class cancer care to Nepal’s Madhesh Province — where it’s needed most. Read more: buff.ly/cn9ZKvY #Binaytara #CancerCare #Nepal #GADA2025

Binaytara Cancer Hospital by Fong & Chan Architects

In Nepal’s Madhesh Province—home to over six million people—access to cancer care has long been out of reach. The Binaytara Cancer Hospital, envisioned as the first dedicated cancer center in the…

awards.re-thinkingthefuture.com